Crain's: Man who received ALS stem cell transplant still doing well
Ted Harada, a 40-year-old man diagnosed with ALS, who received stem cell implantations to his spinal cord in two separate surgeries as part of the first-ever FDA-approved trial of a stem cell therapy for ALS, talked last week with Crain's Detroit business reporter Tom Henderson. Harada said he's still feeling the positive effects he attributes to his second surgery, which took place last August.
"I've been doing great and feeling great." Harada told Henderson. "Just now, the left leg showed a little bit of weakness returning, but I'm still so much better than I was before the surgeries. It's the first time, since August, they've noticed any slight weakness.
"It's clear from the data that the injections reversed my symptoms and slowed down the progression of the disease. I've received a blessing. I almost forget I have ALS. I don't have the constant reminder of having to use the canes. Now, I don't think about ALS every day. Every couple of days something happens and I think, `Oh, yeah, I have ALS.' "
Taubman Institute Director Dr. Eva Feldman received FDA approval in April to move the trial to Phase II, which will study efficacy as well as safety. Patient recruitment has not yet started for that phase of the trial.
Click here to read the entire Crain's blog post.
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Call for applications
Taubman Institute to offer six new scholar grants
The institute is accepting applications through Dec. 1 for its flagshop Taubman Scholar grant program, which is open to clinician-scientists on the U-M Medical School Faculty. Grants are $150,000 per year for three years.
Click here for details
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
Is there a link between tonsils and psoriasis?
Trial tested the effect of tonsillectomy on the skin disease
Taubman Emerging Scholar Dr. Johann Gudjonsson and colleagues found that people who had their tonsils removed showed improvment.
Click here to read the entire story
Fall Visiting Professor Lectures schedule
Distinguished guest speakers include experts in lung, muscle and nerve diseases
Click here for the lineup
Breast cancer clinical trial enrolling patients
Research by Taubman Scholar Dr. Max Wicha into breast cancer stem cells is the basis for a new human clinical trial of the drug Reparixin, which scientists hope will curb the growth of the tumor-fueling cells.